Tags

Type your tag names separated by a space and hit enter

Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
J Cancer Res Ther. 2016 Oct-Dec; 12(4):1291-1297.JC

Abstract

PURPOSE

Although high-mobility group A2 (HMGA2) protein has been reported to participate in cancer progression and metastasis, its clinical relationship with tumor invasion, lymph node metastasis, and prognosis in esophageal squamous cell carcinoma (ESCC) remains unclear. The purpose of this study is to analyze the clinical and prognostic significance of HMGA2 in ESCC patients after curative resection.

MATERIALS AND METHODS

The expression of HMGA2 protein was evaluated by using immunohistochemistry in a tissue microarray (TMA) containing ESCC lesions and adjacent normal esophageal epithelial tissues from 96 patients who had undergone curative resection. TMA was constructed by Shanghai Biochip Co. Ltd., Shanghai, China. The relationship between HMGA2 expression and clinicopathological parameters and prognosis was further analyzed.

RESULTS

HMGA2 expression was significantly higher in ESCC tissues compared with that of the adjacent noncancerous tissues (P < 0.001). High expression of HMGA2 was significantly related to tumor size, lymph node metastasis, and advanced tumor-node-metastasis stage (P < 0.05). Patients with low expression of HMGA2 had a better prognosis than those with high expression (χ2 = 5.069, P = 0.024). Univariate analysis showed that age (P = 0.041), depth of tumor invasion (P = 0.031), lymph node status (P = 0.001), and HMGA2 expression (P = 0.024) were correlated with prognosis. Multivariate analysis showed that HMGA2 expression (hazard ratio [HR]: 0.539; 95% confidence interval [95% CI]: 0.302-0.963, P = 0.037) and lymph node metastasis (HR: 0.504; 95% CI: 0.310-0.820, P = 0.006) were independent prognostic factors for overall survival.

CONCLUSIONS

High HMGA2 expression was related to lymph node metastasis and poor prognosis in ESCC. Our results indicated that HMGA2 could act as a potential biomarker for prognosis evaluation of ESCC patients.

Authors+Show Affiliations

Department of Gastroenterology, Tianjin Hospital of ITCWM, Nankai Hospital, Nankai, Tianjin 300100, China.Department of Urology, Second Hospital of Tianjin Medical University; Sex Hormone Research Center, Tianjin Institute of Urology, Tianjin Medical University, Tianjin 300211, China.Department of Surgery, Tianjin Fourth Hospital, Tianjin 300222, China.Department of Gastroenterology, Tianjin Hospital of ITCWM, Nankai Hospital, Nankai, Tianjin 300100, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28169242

Citation

Wei, Rongna, et al. "Increased Expression of High-mobility Group A2: a Novel Independent Indicator of Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma." Journal of Cancer Research and Therapeutics, vol. 12, no. 4, 2016, pp. 1291-1297.
Wei R, Shang Z, Leng J, et al. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. J Cancer Res Ther. 2016;12(4):1291-1297.
Wei, R., Shang, Z., Leng, J., & Cui, L. (2016). Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Journal of Cancer Research and Therapeutics, 12(4), 1291-1297. https://doi.org/10.4103/0973-1482.180616
Wei R, et al. Increased Expression of High-mobility Group A2: a Novel Independent Indicator of Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma. J Cancer Res Ther. 2016 Oct-Dec;12(4):1291-1297. PubMed PMID: 28169242.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. AU - Wei,Rongna, AU - Shang,Zhiqun, AU - Leng,Jing, AU - Cui,Lihong, PY - 2017/2/8/entrez PY - 2017/2/9/pubmed PY - 2017/3/17/medline SP - 1291 EP - 1297 JF - Journal of cancer research and therapeutics JO - J Cancer Res Ther VL - 12 IS - 4 N2 - PURPOSE: Although high-mobility group A2 (HMGA2) protein has been reported to participate in cancer progression and metastasis, its clinical relationship with tumor invasion, lymph node metastasis, and prognosis in esophageal squamous cell carcinoma (ESCC) remains unclear. The purpose of this study is to analyze the clinical and prognostic significance of HMGA2 in ESCC patients after curative resection. MATERIALS AND METHODS: The expression of HMGA2 protein was evaluated by using immunohistochemistry in a tissue microarray (TMA) containing ESCC lesions and adjacent normal esophageal epithelial tissues from 96 patients who had undergone curative resection. TMA was constructed by Shanghai Biochip Co. Ltd., Shanghai, China. The relationship between HMGA2 expression and clinicopathological parameters and prognosis was further analyzed. RESULTS: HMGA2 expression was significantly higher in ESCC tissues compared with that of the adjacent noncancerous tissues (P < 0.001). High expression of HMGA2 was significantly related to tumor size, lymph node metastasis, and advanced tumor-node-metastasis stage (P < 0.05). Patients with low expression of HMGA2 had a better prognosis than those with high expression (χ2 = 5.069, P = 0.024). Univariate analysis showed that age (P = 0.041), depth of tumor invasion (P = 0.031), lymph node status (P = 0.001), and HMGA2 expression (P = 0.024) were correlated with prognosis. Multivariate analysis showed that HMGA2 expression (hazard ratio [HR]: 0.539; 95% confidence interval [95% CI]: 0.302-0.963, P = 0.037) and lymph node metastasis (HR: 0.504; 95% CI: 0.310-0.820, P = 0.006) were independent prognostic factors for overall survival. CONCLUSIONS: High HMGA2 expression was related to lymph node metastasis and poor prognosis in ESCC. Our results indicated that HMGA2 could act as a potential biomarker for prognosis evaluation of ESCC patients. SN - 1998-4138 UR - https://www.unboundmedicine.com/medline/citation/28169242/Increased_expression_of_high_mobility_group_A2:_A_novel_independent_indicator_of_poor_prognosis_in_patients_with_esophageal_squamous_cell_carcinoma_ L2 - http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2016;volume=12;issue=4;spage=1291;epage=1297;aulast=Wei DB - PRIME DP - Unbound Medicine ER -